Cryopreserved amniotic membrane in the treatment of diabetic foot ulcers: a case series

Autor: Patricio J Alcaraz, Ma Dolores López Lucas, Francisco J. Nicolás, Cristina Fuente Mora, José M. Moraleda, Guadalupe Ruiz Merino, Carmen L. Insausti, Antonio Piñero, Mónica Rodríguez Valiente, Gregorio Castellanos, Miguel Blanquer, Sonia Almansa, Maria del Carmen Algueró, Ana M García-Hernández
Rok vydání: 2018
Předmět:
Zdroj: Journal of Wound Care. 27:806-815
ISSN: 2052-2916
0969-0700
DOI: 10.12968/jowc.2018.27.12.806
Popis: Objective: The amniotic membrane (AM) is a tissue with low immunogenity and high therapeutic potential due to its anti-inflammatory, anti-fibrotic and antimicrobial effects. This paper describes the use of cryopreserved amniotic membrane allografts to treat diabetic foot ulcers (DFUs) in patients with diabetes. Method: In this case series, AM was processed to obtain a final medicinal product: cryopreserved amniotic membrane. cryopreserved AM was applied every 7–10 days until total epithelialisation of the DFUs. Results: A total of 14 patients with DFUs (median size: 12.30cm, (range: 0.52–42.5cm2) were treated and followed up until complete closure (median time: 20 weeks, range: 7–56 weeks). Patients received 4–40 AM applications. All patients in this study achieved complete epithelialisation of the wound. No adverse events were observed. Conclusion: AM is a feasible and safe treatment in complex DFUs. Furthermore, the treatment is successful in achieving epithelialisation of long-evolution, unhealed wounds resistant to conventional therapies.
Databáze: OpenAIRE